KING STREET CAPITAL MANAGEMENT, L.P.KING STREET CAPITAL MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SGRYSGRY

SURGERY PARTNERS INC

1.5M$46.7M32.3%$31.920.00%
1 qtr
New
93
AVAHAVAH

AVEANNA HEALTHCARE HLDGS INC

6.4M$33.3M23.0%$1.67+209.18%
8 qtrssince 2022-Q4
Unchanged
0
19.8M$17.5M12.1%——
6 qtrssince 2023-Q2
Unchanged
0
16.5M$14.4M9.9%——
2 qtrssince 2024-Q2
Unchanged
0
BLCOBLCO

BAUSCH PLUS LOMB CORP

732,065$14.1M9.7%$18.950.00%
1 qtr
New
90
UNITUNIT

UNITI GROUP LLC COM SHS

1.6M$8.8M6.1%$9.700.00%
1 qtr
New
88
OPTUOPTU

OPTIMUM COMMUNICATIONS INC

2.5M$6.2M4.2%$2.04+22.55%
2 qtrssince 2024-Q2
Unchanged
0
AMBPAMBP

ARDAGH METAL PACKAGING S A

1M$3.8M2.6%$2.94+12.93%
2 qtrssince 2024-Q2
Decreased
0
CBCBL
REIT

CBL & ASSOC PPTYS INC

4,582$115,4660.1%$22.84+149.30%
1 qtr
New
33
333,333$20,4670.0%——
6 qtrssince 2023-Q2
Unchanged
0
$144.8M
AUM
10
Positions
Q3 2024
Filing
Rating · 1.5
Quarterly Portfolio Change
-3%Q3'21$1.2B-2%Q4'21$1.2B-8%Q1'22$1.1B-37%Q2'22$674.3M-23%Q3'22$522.1M-72%Q3'24$144.8M
Activity profile
$ moved · Q3'24
New74%Increased0%Decreased12%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q20%1-4Q20%1-2Y30%2Y+30%

KING STREET CAPITAL MANAGEMENT, L.P. manages $144.8M across 10 positions as of Q3 2024. Top holdings: SGRY (32.3%), AVAH (23.0%), UPSTART HLDGS INC (12.1%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1.5/5.0.

Q3 2024 Summary

Added 4 new positions, exited 2, trimmed 1. Top move: SGRY (NEW, conviction 93). Portfolio: $145M across 10 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$145M
SGRY32.28%
AVAH22.98%
UPSTART HLDG12.06%
ANYWHERE REA9.92%
BLCO9.75%
UNIT6.07%
OPTU4.25%
AMBP2.60%
CBL0.08%
ALPHA PARTNE0.01%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors4
Healthcare83.33%
Real Estate7.89%
Communication Services5.44%
Consumer Cyclical3.34%
Fund DNA

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare
Compare DNA across all funds
Fund Rating
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record41
Conviction49
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

D1 Capital Partners L.P.D1 Capital Partners L.P.
$34.8B
JAJericho Capital Asset Management L.P.
$12.1B
Checking access…

Explore More

Compare KING STREET CAPITAL MA…
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Momentum Trader Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with KING STREET CAPITAL MANAG…
Clone this fund
Backtest what copying KING STREET CAPITAL MANAG…'s portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used